Injective (INJ) Faces Short-Term Bearish Pressure After Breaking Key Technical Levels

Injective (INJ) has encountered a notable shift in market momentum, currently changing hands around the $7.24 mark following a decisive breakdown below its established ascending trendline. The recent price action has also seen the digital asset slip beneath the critical 38.2% Fibonacci retracement level, which sits near the $7.35 threshold. This technical development has visibly altered the short-term market structure, tilting the bias in favor of sellers as market participants reassess the immediate trajectory of the asset.

The broader market dynamics surrounding INJ reflect a growing cautiousness among traders and investors. In recent sessions, the price has formed a series of lower highs, a classic bearish characteristic that indicates waning buying pressure and persistent overhead supply. Compounding this technical weakness, the cryptocurrency is currently trading below its key short-term moving averages, signaling that momentum favors the downside in the immediate future unless a strong counter-trend recovery materializes.

Market analysts and chart watchers are closely monitoring how the asset reacts around these crucial inflection points. Attention is currently focused on a potential relief rebound toward the $7.35 region, which previously acted as a supportive floor before turning into overhead resistance. Reclaiming this zone is widely viewed as a necessary first step for buyers looking to stabilize the short-term outlook and neutralize the prevailing downward pressure.

However, if the market fails to muster enough buying interest to reclaim the $7.35 level, the path of least resistance could point toward further retracement. In that scenario, market participants are eyeing a primary support region between $6.60 and $6.80. This targeted zone aligns closely with the 50% Fibonacci retracement level, making it a natural area of interest where buyers might step in to defend valuations and absorb selling pressure.

Should the $6.60 to $6.80 range fail to hold firm against sustained selling, the downward trajectory could extend further toward a deeper accumulation area. Technical models indicate that the next significant potential buy zone sits between $5.85 and $6.05. This lower band corresponds with the 61.8% to 65% Fibonacci retracement levels, a technical confluence that often attracts long-term investors looking for value entries during broader market corrections.

Despite these potential downside targets, experienced market participants are maintaining a disciplined approach, preferring to wait for definitive confirmation rather than attempting to catch falling knives. Many traders are looking for a clear bullish reaction and validated structural confirmation before committing capital to new long positions. Risk management protocols remain a priority, with recommended stop-loss placements situated strictly below relevant support thresholds or underneath recent liquidity sweeps to protect against unexpected volatility spikes.

Ultimately, the short-term fate of Injective hangs in the balance of key technical boundaries. A sustained recovery and successful consolidation above the $7.35 resistance would significantly improve the short-term outlook and invalidate the immediate bearish bias. Conversely, a definitive breakdown below the $5.85 support floor could expose the digital asset to deeper downside risks, prompting a broader reevaluation of market sentiment across the board.

Disclaimer

The information and publications provided in this report are for informational purposes only and are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView or any associated entities. Readers should conduct their own due diligence and consult with qualified financial professionals before making any investment decisions.